CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8
Clinical trials for CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise against advanced melanoma before surgery
Disease control CompletedThis study tested whether giving a combination of targeted drugs (vemurafenib and cobimetinib) and immunotherapy (atezolizumab) before surgery could help people with high-risk stage III melanoma. 64 participants received the treatment, and doctors measured how many had no cancer …
Matched conditions: CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 17, 2026 12:06 UTC
-
New program aims to ease cancer survivors' distress and improve follow-up care
Knowledge-focused CompletedThis study tested a program designed to help adolescent and young adult cancer survivors find healthcare resources and manage their own health. The goal was to see if the program could reduce cancer-related distress and help survivors follow recommended check-ups. 549 survivors o…
Matched conditions: CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:07 UTC